Sangamo Therapeutics, Inc. (LON:0R1D)
0.3938
-0.0145 (-3.55%)
At close: Jan 23, 2026
Sangamo Therapeutics Employees
Sangamo Therapeutics had 183 employees as of December 31, 2024. The number of employees decreased by 222 or -54.81% compared to the previous year.
Employees
183
Change (1Y)
-222
Growth (1Y)
-54.81%
Revenue / Employee
133.64K GBP
Profits / Employee
-442.74K GBP
Market Cap
99.38M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 183 | -222 | -54.81% |
| Dec 31, 2023 | 405 | -73 | -15.27% |
| Dec 31, 2022 | 478 | 47 | 10.90% |
| Dec 31, 2021 | 431 | 18 | 4.36% |
| Dec 31, 2020 | 413 | 59 | 16.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| INSPECS Group | 1,654 |
| BATM Advanced Communications | 867 |
| ECO Animal Health Group | 224 |
| 4basebio | 110 |
Sangamo Therapeutics News
- 3 days ago - Wealth Management Associates, Inc. Sells 20,000 Shares of Sangamo Therapeutics Inc (SGMO) - GuruFocus
- 5 weeks ago - Sangamo (SGMO) Begins BLA Submission for Promising Fabry Disease Therapy - GuruFocus
- 5 weeks ago - Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease - GlobeNewsWire
- 7 weeks ago - Sangamo Therapeutics (SGMO) Surges on FDA Fast Track Designation for ST-503 - GuruFocus
- 7 weeks ago - Sangamo rises as FDA grants Fast Track status to neuropathic pain asset - Seeking Alpha
- 7 weeks ago - Sangamo (SGMO) Gains FDA Fast Track for Chronic Pain Treatment - GuruFocus
- 7 weeks ago - Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy - GlobeNewsWire
- 2 months ago - Sangamo Therapeutics (SGMO) Advances Fabry Disease Therapy with FDA Rolling Submission - GuruFocus